An unhealthy share price reaction
The share price of Sensyne Health has dived following a disappointing trading update suggesting its survival is in doubt. It will be a shame for AIM to lose an exciting company like this, but we think it probably listed too early. Read our thoughts on this and other news here, including an update from one of our Bonkers Bargains. (Free to read)
Sensyne Health: shares dive on terrible announcement Sensyne Health (AIM:SENS), the clinical artificial intelligence company founded and run by Lord Drayson, the former Minister for Science, came out with a humdinger of announcement which saw its shares fall 70%. Sensyne applies clinical AI in the healthcare and life science industries. In healthcare it delivers remote patient monitoring and real-time decision-making systems for healthcare organisations and their patients, while in life sciences it analyses large complex anonymized data sets to help life sciences companies accelerate the development of new medicines. Revenues for its last financial year ending April 2021 leaped more than…